Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/4/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Mark A. Rosenberg

Wrong Dr. Mark A. Rosenberg?


Phone: (561) ***-****  
Email: m***@***.com
The Institute for Healthy Aging
Dr. Mark A. Rosenberg, MD 4800 North Federal Highway Suite B103
Boca Raton , Florida 33431
United States

Company Description: At the Institute for Healthy Aging, we pride ourselves on the practice of cutting edge medicine. This means constantly reviewing the latest studies in the journals...   more

Employment History

Board Memberships and Affiliations


  • M.D.
  • undergraduate degree
    University of Pennsylvania
  • Georgetown University School of Medicine
  • American College of Anti-Aging Medicine
  • MD
  • doctorate
    Georgetown University School of Medicine
175 Total References
Web References
Life Length | Scientific Advisory Board, 4 Feb 2016 [cached]
Mark Rosenberg
Mark Rosenberg, M.D. Scientific Advisor
Dr. Mark Rosenberg, M.D. is the President of The Institute for Healthy Aging; at this center, patients are treated with the combination of conventional and complementary techniques. In addition, Dr. Rosenberg is the program director for the first and only existing Integrative Cancer Fellowship in the U.S. He is now collaborating with doctors from Yale and Harvard, as well as researchers from Cancer Treatment Centers of America and will soon be initiating the first human clinical trial on advanced-stage cancer patients using his novel technique. This technique has been successful in causing an apparent "complete remission" in a patient with metastatic (stage 4) endometrial carcinoma. Dr. Rosenberg obtained his M.D. at Georgetown University School of Medicine in 1988.
New Cancer Treatment Techniques - The Institute for Healthy Aging, 14 Jan 2011 [cached]
About Dr. Rosenberg Anti-aging Medicine
Boca Raton, FL January 14, 2011: Dr. Mark Rosenberg, Medical Director of the Institute for Healthy Aging and Director of the Integrative Cancer Therapies Fellowship with the American Academy of Anti-Aging Medicine, announced the preliminary findings of a novel technique for treating advanced-stage cancer. Using a process that Dr. Rosenberg calls, "Cancer pH Manipulation Therapy," he was able to completely normalize tumor markers in four weeks in a patient with metastatic endometrial carcinoma without the use of chemotherapy.
Dr. Rosenberg has begun treating a second patient with this therapy, who has been diagnosed with stage IIIC primary peritoneal carcinoma. Her tumor marker had been rapidly rising prior to Dr. Rosenberg's treatment. Using his protocol, Dr. Rosenberg achieved a 40% reduction in tumor markers in just two weeks.
Dr. Rosenberg's treatment targets cancers that feed on glucose, and process the glucose through a mechanism known as glycolysis. Most cancers (both stem cells and non-stem cells) rely more heavily on glycolysis relative to normal tissue. The end product of glycolysis is lactic acid. Based on Dr. Rosenberg's in-vitro study at University of Miami, he developed an oral protocol which blocks three mechanisms that cancer cells use to efflux lactic acid. Effluxing lactic acid is essential for the cancer cells to prevent apoptosis (programmed cell death); in addition, as the cancer cells efflux lactic acid and acidify their extracellular ilieu, the resulting acidity promotes the aggressiveness of the cancer. After Dr. Rosenberg ensures that the acid pumps are blocked, he literally feeds the cancer cells by infusing high dose glucose. As the cancer cells feed, they create lactic acid that is unable to be pumped out of the cells. In Dr. Rosenberg's words, "the more they eat the faster they die."
About Mark Rosenberg, M.D.
For the past 15 years Dr. Mark Rosenberg has combined modern medicine with nutrition, exercise, and physiology to create a natural program for healthier living. Dr. Rosenberg received his undergraduate degree from University of Pennsylvania and graduated from Georgetown University School of Medicine. He then completed his residency in emergency medicine in San Antonio, Texas at Brooke Army Medical Center, where he won the award of "Teacher and Resident of the Year."
Dr. Rosenberg has been involved with drug research since 1991. Having studied the mechanisms of cancer treatment failure, the following concept has become blatantly apparent to Dr. Rosenberg. There are many substances that are toxic to cancer cells in vitro (outside of the body, in a culture medium), including chemotherapy and intravenous antioxidant therapy. These therapies, however, are more often than not, ineffective inside the body. The primary reason for the ineffectiveness is that tumor blood flow is poor, resulting in a tumor that actually receives very little of the cytotoxic therapy that is being administered. In addition, poor tumor blood flow is associated with higher grade tumors and greater incidence of metastasis. Knowing this, Dr. Rosenberg developed a novel protocol that integrates standard chemotherapeutic regimens with non-toxic natural supplemental regimens.
Dr. Rosenberg has since concentrated his efforts on improving blood flow to the cancer, while administering cytotoxic intravenous antioxidant therapy. In addition to using vasodilating therapy such as carbogen and isosorbide dinitrate, Dr. Rosenberg has just been granted approval status for an IND (investigational new drug) using Angiotensin II. Angiotensin II is frequently used in Japan in conjunction with chemotherapy to improve tumor blood flow.
Dr. Rosenberg was featured on Fox News for inducing remission in a patient with cancer that had spread from the lungs to the liver and spine. In 1997, Dr. Rosenberg became a diplomate of the American College of Anti-Aging Medicine. He has since become a highly sought-after speaker, lecturing frequently on topics such as integrative cancer therapy and anti-aging medicine. In 2009, Dr. Rosenberg regularly lectured in Asia, Europe, and the Middle East. He published a physician's guide to the treatment of drug toxicities and served as a consultant to several hospitals for the treatment of drug overdoses. In addition to drug research, he is avidly involved in supplement research, and has served as the Chief Science Officer for several supplement companies including VitalMax Vitamins.
Dr. Mark A Rosenberg serves as Director of the Fellowship in Integrative Cancer Therapy.
Created by Mark Rosenberg, ... [cached]
Created by Mark Rosenberg, M.D., founder of The Institute of Healthy Aging, Prostanol features a unique, sterol-rich blend called Phytosin, which Rosenberg claims reduces prostate or urinary problems, such as frequent urination and prostate inflammation. These results may be seen in mere weeks, with lasting results seen after only one month of use.
Integrative Cancer Research and Treatment (AugSept 2012) Townsend Letter for Doctors & Patients, 9 Dec 2012 [cached]
Mark Rosenberg, MD: Integrative Cancer Research and Treatment Integrative Cancer Research and Treatment (AugSept 2012) Townsend Letter for Doctors & Patients
Mark Rosenberg, MD: Integrative Cancer Research and Treatment
Mark Rosenberg
MARK ROSENBERG, MD Dr. Rosenberg received his medical degree from Georgetown University School of Medicine and serves as director of the Fellowship in Integrative Cancer Therapy with the American Academy of Anti-aging Medicine, the first and only fellowship of its kind in the United States. His clinical practice in anti-aging medicine is located in Boca Raton at the Institute for Healthy Aging. He is chief medical Officer for LifeLength, which provides lab testing on telomere health as a marker of aging; and chief science director of Research and Development for Vitalmax Vitamins.
Dr. Rosenberg has been involved in the research and development of pharmaceuticals since 1991. In 2001, he developed and patented a drug to aid in the management of obesity and diabetes, and he also has a patent pending for an oral appetite suppressant. He is currently researching novel compounds to treat cancer and has received approval status for a new investigational drug that works in conjunction with chemotherapy.
Cancer Treatment in the United States: An Ongoing Travesty | Foundation for Alternative and Integrative Medicine, 13 Aug 2015 [cached]
Dr. Mark A. Rosenberg, Guest Writer
Mark A. Rosenberg
Dr. Mark A. Rosenberg
Dr. Mark Rosenberg is President of The Institute for Healthy Aging and Director of the American Academy of Anti-Aging Medicine's Fellowship in Integrative Cancer Therapies. Read more...
Other People with the name "Rosenberg":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.